Rome, Italy

Alessandra Fierabracci

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Ospedale Pediatrico Bambino Gesu'. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alessandra Fierabracci. Retrieved from https://idiyas.com/inventor/alessandra-fierabracci

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alessandra Fierabracci: Innovator in RNA Therapeutics

Introduction

Alessandra Fierabracci is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of medical research, particularly in the area of RNA therapeutics. Her work focuses on innovative solutions for the prevention and treatment of autoimmune diseases.

Latest Patents

Alessandra holds a patent for a short interfering RNA targeting the variant C1858T of the gene PTPN22. This invention involves short interfering RNA duplexes (siRNA) that have potential applications in the medical field, specifically aimed at addressing autoimmune diseases.

Career Highlights

Alessandra is affiliated with Ospedale Pediatrico Bambino Gesù, where she continues to advance her research and contribute to the medical community. Her dedication to innovation in RNA technology has positioned her as a key figure in her field.

Conclusion

Alessandra Fierabracci's work exemplifies the impact of innovative research in medicine. Her patent on RNA therapeutics highlights her commitment to improving health outcomes for individuals with autoimmune diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…